These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
490 related articles for article (PubMed ID: 24408866)
21. Future directions in the treatment of cholangiocarcinoma. Zhu AX Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):355-61. PubMed ID: 25966434 [TBL] [Abstract][Full Text] [Related]
22. Aberrant GLUT1 Expression Is Associated With Carcinogenesis and Progression of Liver Fluke-associated Cholangiocarcinoma. Thamrongwaranggoon U; Sangkhamanon S; Seubwai W; Saranaruk P; Cha'on U; Wongkham S In Vivo; 2021; 35(1):267-274. PubMed ID: 33402473 [TBL] [Abstract][Full Text] [Related]
23. New and Emerging Systemic Therapeutic Options for Advanced Cholangiocarcinoma. Massironi S; Pilla L; Elvevi A; Longarini R; Rossi RE; Bidoli P; Invernizzi P Cells; 2020 Mar; 9(3):. PubMed ID: 32168869 [TBL] [Abstract][Full Text] [Related]
24. Molecular pathways and targeted therapy in cholangiocarcinoma. Dabney RS; Khalife M; Shahid K; Phan AT Clin Adv Hematol Oncol; 2019 Nov; 17(11):630-637. PubMed ID: 31851165 [TBL] [Abstract][Full Text] [Related]
25. Genomic and transcriptional alterations of cholangiocarcinoma. Ito T; Sakurai-Yageta M; Goto A; Pairojkul C; Yongvanit P; Murakami Y J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):380-7. PubMed ID: 24532422 [TBL] [Abstract][Full Text] [Related]
26. Monitoring the Progression of Liver Fluke-Induced Cholangiocarcinoma in a Hamster Model Using Synchrotron FTIR Microspectroscopy and Focal Plane Array Infrared Imaging. Chatchawal P; Wongwattanakul M; Tippayawat P; Jearanaikoon N; Jumniansong A; Boonmars T; Jearanaikoon P; Wood BR Anal Chem; 2020 Dec; 92(23):15361-15369. PubMed ID: 33170647 [TBL] [Abstract][Full Text] [Related]
27. Overexpression of PDGFA and its receptor during carcinogenesis of Opisthorchis viverrini-associated cholangiocarcinoma. Boonjaraspinyo S; Wu Z; Boonmars T; Kaewkes S; Loilome W; Sithithaworn P; Nagano I; Takahashi Y; Yongvanit P; Bhudhisawasdi V Parasitol Int; 2012 Mar; 61(1):145-50. PubMed ID: 21777692 [TBL] [Abstract][Full Text] [Related]
28. Amplification of D22S283 as a favorable prognostic indicator in liver fluke related cholangiocarcinoma. Thanasai J; Limpaiboon T; Jearanaikoon P; Bhudhisawasdi V; Khuntikeo N; Sripa B; Miwa M World J Gastroenterol; 2006 Jul; 12(27):4338-44. PubMed ID: 16865775 [TBL] [Abstract][Full Text] [Related]
29. A review of the clinical diagnosis and therapy of cholangiocarcinoma. Yao D; Kunam VK; Li X J Int Med Res; 2014 Feb; 42(1):3-16. PubMed ID: 24366497 [TBL] [Abstract][Full Text] [Related]
30. Highlights of topic "Biochemical and molecular pathological aspects of cholangiocarcinoma". Murakami Y J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):359-61. PubMed ID: 24840727 [No Abstract] [Full Text] [Related]
31. Risk biomarkers for assessment and chemoprevention of liver fluke-associated cholangiocarcinoma. Yongvanit P; Pinlaor S; Loilome W J Hepatobiliary Pancreat Sci; 2014 May; 21(5):309-15. PubMed ID: 24408859 [TBL] [Abstract][Full Text] [Related]
32. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma. Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228 [TBL] [Abstract][Full Text] [Related]
33. Systemic therapy for hepatocellular carcinoma and cholangiocarcinoma. Chung V Surg Oncol Clin N Am; 2015 Jan; 24(1):187-98. PubMed ID: 25444475 [TBL] [Abstract][Full Text] [Related]
34. MRI and (1)H MRS findings of hepatobilary changes and cholangiocarcinoma development in hamsters infected with Opisthorchis viverrini and treated with N-nitrosodimethylamine. Hanpanich P; Pinlaor S; Charoensuk L; Yongvanit P; Chamgramol Y; Pairojkul C; Mairiang E Magn Reson Imaging; 2015 Nov; 33(9):1146-1155. PubMed ID: 26117689 [TBL] [Abstract][Full Text] [Related]
35. Contribution of RIZ1 to regulation of proliferation and migration of a liver fluke-related cholangiocarcinoma cell. Khaenam P; Niibori A; Okada S; Jearanaikoon P; Araki N; Limpaiboon T Asian Pac J Cancer Prev; 2012; 13(8):4007-11. PubMed ID: 23098508 [TBL] [Abstract][Full Text] [Related]
36. Advances in targeted therapy of cholangiocarcinoma. Li Y; Yu J; Zhang Y; Peng C; Song Y; Liu S Ann Med; 2024 Dec; 56(1):2310196. PubMed ID: 38359439 [TBL] [Abstract][Full Text] [Related]